Discover how we are supporting innovation in rare disease:
Imagining a future where rare diseases patients have a better chance at a healthy life, an oped by Nathalie Moll, EFPIA Director General
Advancing innovation for rare disease patients: a call to action on Rare Disease Day 2024, an oped by Ricardo Marek, President Europe and Canada at Takeda
Rare Disease Moonshot supports the EURORDIS-Rare Diseases Europe’s call for an EU action plan
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.